The Effect of LINAGLIPTIN on Inflammation, Oxidative Stress and Insulin Resistance in Obese Type 2 Diabetes Subjects
Clinical trial NCT02372630 · COMPLETED
Trial details
- NCT number
- NCT02372630
- Sponsor
- University at Buffalo
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-23
- Primary completion
- 2018-02-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.